Loading…
Sanara MedTech Inc. is projected to rise to $26.00 by 2027, a +11% move from its current price of $23.38. SMTI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $22.72 | $23.40 | $24.11 | +0.10% |
| May 30 | $22.46 | $23.42 | $24.43 | +0.19% |
| May 31 | $22.27 | $23.45 | $24.69 | +0.29% |
| Jun 1 | $22.11 | $23.47 | $24.91 | +0.38% |
| Jun 2 | $21.98 | $23.49 | $25.11 | +0.48% |
| Jun 3 | $21.86 | $23.51 | $25.29 | +0.57% |
| Jun 4 | $21.76 | $23.54 | $25.46 | +0.67% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $21.76 | $23.54 | $25.46 | +0.67% |
| Week 2 | $21.20 | $23.69 | $26.48 | +1.35% |
| Week 3 | $20.82 | $23.85 | $27.33 | +2.03% |
| Week 4 | $20.52 | $24.01 | $28.10 | +2.71% |
| Week 5 | $20.28 | $24.18 | $28.82 | +3.40% |
| Week 6 | $20.07 | $24.34 | $29.51 | +4.09% |
| Week 7 | $19.90 | $24.50 | $30.17 | +4.79% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sanara MedTech Inc. is a medical technology company that develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.
It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingrowth across the graft site; ACTIGEN Inductive Bone Matrix, a naturally derived, differentiated allograft matrix with robust handling properties; ALLOCYTE Plus, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc.
was incorporated in 2001 and is based in Fort Worth, Texas.
Sanara MedTech Inc. (SMTI) is currently priced at $23.17 and has a market cap of $212.33M, with a market position listed at rank 3798. The current price sits within a broader technical context that shows a bullish tilt alongside a bullish longer-term forecast.
The 30-day technical picture complements this view with momentum indicators and defined support/resistance levels that frame near-term action.
A major floor 31.3% below — a decisive break under it would weaken the trend.
The nearest floor, 22.9% below — buyers have tended to step in here.
Price is pressing into resistance (1.1% away) — a breakout level to watch.
A major ceiling 16.8% above — clearing it would confirm fresh momentum.
Key SMTI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SMTI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $23.22 | Buy | $23.02 | Buy |
| MA 10 | $22.45 | Buy | $22.35 | Buy |
| MA 20 | $20.76 | Buy | $21.33 | Buy |
| MA 50 | $19.30 | Buy | $20.31 | Buy |
| MA 100 | $20.22 | Buy | $20.90 | Buy |
| MA 200 | $24.27 | Sell | $23.15 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.37 | Neutral |
| Stoch RSI (14) | 85.94 | Sell |
| CCI (20) | 103.12 | Buy |
| Williams %R (14) | -4.63 | Info |
| MACD (12,26,9) | 0.29 | Buy |
| ROC (12) | 27.07 | Buy |
| Bollinger %B (20,2) | 0.85 | Neutral |
| Stochastic %K (14) | 95.37 | Sell |
| TRIX (15) | 0.65 | Buy |
| Awesome (5,34) | 3.17 | Buy |
| Ultimate (7,14,28) | 75.94 | Sell |
| Momentum (10) | 2.94 | Buy |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 23.58 | Sell |
| ADX (14) | 21.69 | Buy |
| ATR (14) | 0.59 | Info |
The 30-day technical picture is bullish, with RSI at 70 signaling strong momentum. The 50-day simple moving average sits at $19.15, while the 200-day simple moving average is at $24.28, illustrating a near-term crossover dynamic around the mid-$20s range. Support is identified at $17.60 and resistance at $23.64, giving a clear, tradable band around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.34 | $23.38 | $32.02 | 0% | Neutral | |
| $20.44 | $26.00 | $35.13 | +11% | Neutral | |
| $21.97 | $28.79 | $40.42 | +23% | Bullish | |
| $25.79 | $34.66 | $50.16 | +48% | Bullish | |
| $29.36 | $40.33 | $59.88 | +72% | Bullish | |
| $32.39 | $45.42 | $68.96 | +94% | Bullish | |
| $32.96 | $47.10 | $72.96 | +101% | Bullish | |
| $32.87 | $47.82 | $75.44 | +105% | Bullish | |
| $34.57 | $51.17 | $82.08 | +119% | Bullish | |
| $35.54 | $53.46 | $87.11 | +129% | Bullish | |
| $50.81 | $82.38 | $143.24 | +252% | Bullish | |
| $95.48 | $176.38 | $337.12 | +654% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $16.34 | $23.38 | $27.54 | +0.00% |
| June 2026 | $20.84 | $24.52 | $29.57 | +4.88% |
| July 2026 | $21.48 | $25.51 | $31.22 | +4.03% |
| August 2026 | $21.17 | $25.32 | $31.34 | -0.73% |
| September 2026 | $21.21 | $25.52 | $31.87 | +0.78% |
| October 2026 | $21.77 | $26.34 | $33.17 | +3.22% |
| November 2026 | $21.42 | $26.04 | $33.03 | -1.15% |
| December 2026 | $20.53 | $25.08 | $32.02 | -3.70% |
Click any year to see its month-by-month SMTI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, SMTI is projected to trade between $16.34 and $32.02, averaging $23.38 — a potential gain of 0% from today's $23.38. Price action looks broadly range-bound.
Sanara MedTech Inc.'s 2027 outlook centres on $26.00, within a $20.44 to $35.13 range. That is up +11% on the projected 2026 average. That marks a +11% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, SMTI could reach as high as $40.42, with a base case around $28.79 and support toward $21.97 — roughly +23% from $23.38. Momentum favours further upside here.
Expect SMTI to range from $25.79 to $50.16 through 2029. The $34.66 average target implies a +48% move from current prices. That is up +20% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The SMTI price prediction for 2030 points to an average of $40.33 (low $29.36, high $59.88) — a potential gain of +72% on today's $23.38. Momentum favours further upside here.
In 2031, SMTI is projected to trade between $32.39 and $68.96, averaging $45.42 — a potential gain of +94% from today's $23.38. That is up +13% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Sanara MedTech Inc.'s 2032 outlook centres on $47.10, within a $32.96 to $72.96 range. That is up +4% on the projected 2031 average. That marks a +101% change versus current levels. Momentum favours further upside here.
By 2033, SMTI could reach as high as $75.44, with a base case around $47.82 and support toward $32.87 — roughly +105% from $23.38. Buyers look set to stay in control over this stretch.
Expect SMTI to range from $34.57 to $82.08 through 2034. The $51.17 average target implies a +119% move from current prices. That is up +7% on the projected 2033 average. Momentum favours further upside here.
The SMTI price prediction for 2035 points to an average of $53.46 (low $35.54, high $87.11) — a potential gain of +129% on today's $23.38. Buyers look set to stay in control over this stretch.
In 2040, SMTI is projected to trade between $50.81 and $143.24, averaging $82.38 — a potential gain of +252% from today's $23.38. That is up +54% on the projected 2035 average. Momentum favours further upside here.
Sanara MedTech Inc.'s 2050 outlook centres on $176.38, within a $95.48 to $337.12 range. That is up +114% on the projected 2040 average. That marks a +654% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in SMTI today (≈ 42.7716 SMTI) could be worth
$7,544.13
+$6,544.13 (+654%) by 2050 · US Dollar
Based on the average projected SMTI price of $176.38 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SMTIwould be worth at today's price.
$1,000 invested in SMTI on May 27, 2025 (≈ 32.488628 SMTI) would be worth
$759.58
-$240.42 (-24.0%) today · 0.76× · US Dollar
Based on a SMTI entry price of $30.78 vs. today's $23.38.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $23 | $1,016.52 | +1.7% |
| 1 month ago | $18.93 | $1,235.08 | +23.5% |
| 3 months ago | $21.07 | $1,109.63 | +11.0% |
| 6 months ago | $20.92 | $1,117.59 | +11.8% |
| 1 year ago | $30.78 | $759.58 | -24.0% |
| All time (5.0y) ago | $29.2 | $800.68 | -19.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SMTI forecast.
Our base-case forecast reaches $47.00 around 2032.
Implied market cap at $47.00: $430.71M
Forecast data show a multi-year path with rising averages and expanding upside. The 2026 forecast has an average of $23.17 and a max of $31.76, with a neutral sentiment and 0% ROI. By 2027 the average rises to $25.75 and the max to $35.07, with an 11.1% ROI and neutral sentiment; subsequent years turn bullish as the averages climb to higher levels and ROI expands.
In 2030 the average is $39.67 with a max of $59.60 and a 71.2% ROI, and by 2040 the average reaches $78.85 with a max of $139.53 and a 240.3% ROI, reflecting stronger upside potential. By 2050 the average is $169.12 and the max $329.98, with a 629.9% ROI and a bullish sentiment. These figures imply a sustained, long-run upside, though 2026 remains neutral and every forecast is an estimate, not a guarantee.
Tap a question to reveal the answer.
2030 forecast: min $28.57, avg $39.67, max $59.60, ROI 71.2%, sentiment BULLISH.
The forecast shows upside over time, with 2050 avg $169.12, max $329.98 and ROI 629.9% (bullish), though 2026 starts neutral and these are estimates, not guarantees.
Yes, the max forecast reaches $139.53 by 2040 and $329.98 by 2050, after earlier years with lower max values.
30-day range is $18.85 to $28.48, with RSI at 70, and near-term support at $17.60 and resistance at $23.64.
Current price is $23.17 and market cap is $212.33M; the rank is 3798.
Sanara MedTech Inc. Community Discussion
0Share your Sanara MedTech Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.